@article{735f5670acdd4f63b9210e97af0d5cc9,
title = "Reduced folate carrier(RFC)及びdihydrofolate reductase(DHFR)mRNA発現量の定量は骨肉腫化学療法の治療効果予測因子とはならない",
keywords = "Carrier Proteins, Methotrexate(治療的利用), PCR法, Dihydrofolate Reductase, 腫瘍遺伝子発現調節, *骨肉腫(薬物療法,予後), MRI, 治療成績, 抗腫瘍剤耐性, 大量薬物療法, *Reduced Folate Carrier Protein, ヒト, 小児(6～12), 青年期(13～18), 成人(19～44), 男, 女",
author = "時崎 暢",
year = "2004",
month = may,
language = "Japanese",
volume = "27",
pages = "191--201",
journal = "Teikyo Medical Journal",
issn = "0387-5547",
publisher = "Teikyo University School of Medicine",
number = "3",
}